4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-282735
Chief Operating Officer sold 2,175 shares at $20.00 ($43,500)
- Chief Operating Officer acquired 2,175 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Champoux Jennifer · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,175 | $3.98 | $8,657 | 64,546 | D |
| 2026-06-23 | Sale : show line 2 in the form 10b5-1 | −2,175 | $20.00 | $43,500 | 62,371 | D |
| Open-market sales · 2,175 sh · avg $20.00 · $43,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-23 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −2,175 | 31,298 | D |
Loading xslF345X06/ownership.xml…